Stock Research: Medibank Private

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Medibank Private

ASX:MPL AU000000MPL3
87
  • Value
    54
  • Growth
    29
  • Safety
    Safety
    33
  • Combined
    66
  • Sentiment
    72
  • 360° View
    360° View
    87
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Medibank Private Limited is an Australia-based health company offering health insurance policies under the Medibank and ahm brands. The company operates in the health insurance and health management industries, providing hospital and ancillary cover, as well as telehealth services. It primarily operates in Australia. In the last fiscal year, the company had a market cap of $9,146 million and 3220 employees. Revenue and profits are unavailable.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 87 (better than 87% compared with alternatives) for 2022, overall professional sentiment and financial characteristics for the stock Medibank Private are very positive. The 360° View is based on consolidating four consolidated indicators, with half below and half above average for Medibank Private. The consolidated Sentiment Rank has a good rank of 72, which means that professional investors are more optimistic about the stock than for 72% of alternative investment opportunities. It also rates well regarding its financing structure, with the consolidated Safety Rank at 54 or better than 54% of its peers when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. But the stock is expensive and expects low growth. The consolidated Value Rank is only 33, meaning that the share price of Medibank Private is on the high side, compared with indicators such as revenues, profits, and invested capital. The company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth,and stock returns, with its Growth Rank at 29. ...read more

more
Index
ASX 100
ASX 200
ASX 300
ASX 50
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
33 47 55 53
Growth
29 35 81 49
Safety
Safety
54 54 54 54
Sentiment
72 93 100 88
360° View
360° View
87 87 87 81
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
28 39 59 41
Opinions Change
50 56 50 82
Pro Holdings
n/a 96 97 86
Market Pulse
89 93 96 72
Sentiment
72 93 100 88
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
33 47 55 53
Growth
29 35 81 49
Safety Safety
54 54 54 54
Combined
66 66 66 66
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
20 32 34 32
Price vs. Earnings (P/E)
76 71 72 69
Price vs. Book (P/B)
7 9 12 21
Dividend Yield
63 71 66 69
Value
33 47 55 53
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
38 40 51 47
Profit Growth
37 34 49 35
Capital Growth
11 62 59 41
Stock Returns
77 47 87 75
Growth
29 35 81 49
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
82 84 94 85
Refinancing
50 50 50 50
Liquidity
90 89 91 86
Safety Safety
54 54 54 54

Similar Stocks

Discover high‑ranked alternatives to Medibank Private and broaden your portfolio horizons.

MS&AD Insurance

TSE:8725
Country: Japan
Industry: Property & Casualty Insurance
Size: Large
Full Stock Analysis

Mitsubishi UFJ Lease & Finance

TSE:8593
Country: Japan
Industry: Specialized Finance
Size: X-Large
Full Stock Analysis

T&Ds

TSE:8795
Country: Japan
Industry: Life & Health Insurance
Size: Large
Full Stock Analysis

Flight Centre Travel

ASX:FLT
Country: Australia
Industry: Hotels, Resorts & Cruise Lines
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.